Share

Celgene CEO: FDA places 'FUSION' trials on hold in 'cautionary approach'

We're stopping now to understand what's happening, says Mark Alles, Celgene CEO, talking about the company's latest cancer drug trials.
02:09
Thu, Sep 7 20178:50 AM EDT